Multicenter Phase 1b/2 Study of Tivozanib in Patients With Advanced Inoperable Hepatocellular Carcinoma
Active, no longer recruiting
Phase of Trial: Phase I/II
Latest Information Update: 23 May 2017
At a glance
- Drugs Tivozanib (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 07 Jun 2017 Biomarkers information updated
- 22 Feb 2017 Planned primary completion date changed from 1 Mar 2017 to 14 Aug 2017.
- 22 Feb 2017 Status changed from recruiting to active, no longer recruiting.